Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 22, 2021

SELL
$160.2 - $186.42 $1,922 - $2,237
-12 Closed
0 $0
Q1 2021

Apr 12, 2021

BUY
$150.19 - $173.5 $300 - $347
2 Added 20.0%
12 $2,000
Q3 2020

Oct 28, 2020

SELL
$105.46 - $144.13 $6,643 - $9,080
-63 Reduced 86.3%
10 $1,000
Q2 2020

Jul 20, 2020

BUY
$95.68 - $121.88 $956 - $1,218
10 Added 15.87%
73 $8,000
Q4 2019

Jan 24, 2020

BUY
$117.65 - $153.73 $117 - $153
1 Added 1.61%
63 $9,000
Q1 2019

Apr 12, 2019

BUY
$121.81 - $142.95 $852 - $1,000
7 Added 12.73%
62 $9,000
Q4 2018

Jan 30, 2019

SELL
$115.94 - $166.74 $3,246 - $4,668
-28 Reduced 33.73%
55 $7,000
Q3 2018

Nov 01, 2018

BUY
$161.01 - $180.57 $4,508 - $5,055
28 Added 50.91%
83 $13,000
Q4 2017

Feb 09, 2018

SELL
$131.06 - $150.39 $1,048 - $1,203
-8 Reduced 12.7%
55 $7,000
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $8,985 - $9,802
63
63 $9,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.8B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.